Status:
UNKNOWN
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP
Lead Sponsor:
Shandong University
Collaborating Sponsors:
Traditional Chinese Medicine Hospital Affiliated to Shandong University
Jinan Central Hospital
Conditions:
Immune Thrombocytopenia
Eligibility:
All Genders
18-80 years
Brief Summary
It seems reasonable to assume that patients who present significant bleeding symptoms may have different quality of platelets than those without bleeding. This question was addressed in a study that e...
Detailed Description
The investigators are undertaking a prospective multicenter double-blind study of 400 adult patients with immune thrombocytopenia from 6 medical centers in China. We adopted three different assays tha...
Eligibility Criteria
Inclusion
- Untreated adult ITP patients of both genders between the ages of 18 and 80 years.
- Participants of either acute or chronic phase; with or without thrombocytopenia; with or without bleeding manifestation.
Exclusion
- Received high-dose steroids or IVIG within 3 weeks prior to the test.
- Received second-line ITP-specific treatments (eg, cyclophosphamide, 6-mercaptopurine, vincristine, vinblastine, etc) within 3 months prior to the test.
- Current HIV infection, hepatitis B virus or hepatitis C virus infections.
- Severe medical condition (liver and kidney function impairment).
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03377439
Start Date
December 1 2017
End Date
December 1 2018
Last Update
December 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital, Shandong University
Jinan, Shandong, China, 250012